Results 81 to 90 of about 34,040 (268)

Skin‐Reducing Mastectomy and Implant Reconstruction: Long‐Term Surgical, Oncological, and Patient‐Reported Outcomes

ANZ Journal of Surgery, EarlyView.
ABSTRACT Background Skin‐reducing mastectomy (SRM) allows implant‐based immediate breast reconstruction in women with large, ptotic breasts. This study aimed to evaluate the surgical and patient‐reported outcomes (PRO) following SRM. Methods A retrospective analysis was conducted on patients who underwent SRM between January 2011 and December 2014 ...
Gaik Si Quah, Meagan Brennan, James French, Elisabeth Elder   +3 more
wiley   +1 more source

Sentinel Lymph Node Evaluation: What the Radiologist Needs to Know

Diagnostics, 2019
Axillary lymph node status is the single most important prognostic indicator in patients with breast cancer. Axillary lymph node dissection, the traditional method of staging breast cancer, is associated with significant morbidity.
Gary J. Whitman, Raya H. AlHalawani, Niloofar Karbasian, Rajesh Krishnamurthy   +3 more
doaj   +1 more source

Lymphoscintigraphy with peritumoral injection versus lymphoscintigraphy with subdermal periareolar injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients [PDF]

, 2014
Background: Preoperative lymphoscintigraphy is without doubt a valid method for the detection of the sentinel lymph node (SLN). There has been considerable debate regarding the optimal site for the introduction of the tracer; various sites include ...
CARUSO, Giuseppe, CIPOLLA, Calogero, Costa, R, Fricano, S, LATTERI, Mario, Latteri, S, Morabito, A, SALERNO, Sergio   +7 more
core   +1 more source

Pembrolizumab for Early‐Stage Triple‐Negative Breast Cancer: KEYNOTE‐522 Japan Subgroup Analysis

Cancer Science, EarlyView.
In the global, phase 3 KEYNOTE‐522 study of high‐risk early‐stage triple‐negative breast cancer (TNBC), neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab improved efficacy outcomes versus neoadjuvant chemotherapy alone. In this analysis of Japanese participants from KEYNOTE‐522, neoadjuvant pembrolizumab plus chemotherapy ...
Masato Takahashi, Hirofumi Mukai, Toshimi Takano, Koichiro Tsugawa, Kenichi Inoue, Mitsuya Itoh, Junichiro Watanabe, Yuko Tanabe, Naohito Yamamoto, Yasuo Miyoshi, Kenichi Watanabe, Toru Mukohara, Yibin Kong, Masashi Shimura, Francisco Beca, Peter Schmid, Hiroji Iwata   +16 more
wiley   +1 more source

Minimize the extent and morbidity of axillary dissection for node-positive breast cancer patients: implementation of axillary lymph node dissection based on breast lymphatics level

BMC Cancer, 2021
Background Breast cancer-related lymphedema (BCRL) is associated with extensive axillary dissection. Axillary lymph node dissection (ALND) based on breast lymphatics level (BLL) was proposed to minimize the surgical extent for node-positive breast cancer
Qianqian Yuan, Jinxuan Hou, Yukun He, Yiqian Liao, Lewei Zheng, Gaosong Wu   +5 more
doaj   +1 more source

ASO Visual Abstract: Contemporary Axillary Management in cT1-2N0 Breast Cancer with 1–2 Positive Sentinel Lymph Nodes: Factors Associated with Completion Axillary Lymph Node Dissection Within the National Cancer Database [PDF]

, 2022
Arielle P. Stafford, Tanya L. Hoskin, Courtney N. Day, Stacy B. Sanders, Judy C. Boughey   +4 more
openalex   +1 more source

Axillary Lymph Node Dissection for T1a Breast Carcinoma [PDF]

Obstetrical & Gynecological Survey, 1994
Axillary dissection has been a routine part of breast cancer treatment for more than 100 years. Axillary node involvement is the single most important prognostic variable in patients with breast cancer. Recently, routine node dissection has been eliminated for intraductal carcinoma because so few patients had positive nodes.
M J, Silverstein, E D, Gierson, J R, Waisman, G M, Senofsky, W J, Colburn, P, Gamagami   +5 more
openaire   +2 more sources

Complete lymph node dissection versus selective lymph node extirpation in melanoma patients with nodal macrometastasis and adjuvant systemic therapy

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Complete lymph node dissection (CLND) is the standard of care in patients with regional nodal melanoma macrometastasis. However, evidence on surgical procedures in the era of adjuvant systemic therapies is lacking. Patients and Methods This retrospective multi‐center study included stage IIIB–D melanoma patients with ...
Kristine E. Mayer, Jessica C. Hassel, Jannik Sambale, Michael Erdmann, Mihaela‐Anca Sindrilaru, Julia Oberschmied, Alexander Thiem, Dirk Tomsitz, Jana Knuever, Max Schlaak, Carola Berking, Christian Posch, Tilo Biedermann, Oana‐Diana Persa   +13 more
wiley   +1 more source

Sequelae following axillary lymph node dissection for breast cancer

Expert Review of Anticancer Therapy, 2006
Axillary lymph node dissection (ALND) has a central role in the surgical management of breast cancer; however, it is associated with a potentially significant morbidity. Although post-ALND complications are often minor, in some cases they can persist for a long time following surgery, thereby affecting the quality of life of breast cancer survivors ...
Sakorafas GH, Peros G, CATALIOTTI, LUIGI
openaire   +4 more sources